• About Merz Aesthetics

    With numerous innovative products for the treatment of skin, Merz Aesthetics is one of the leaders in asthetic medicine. A broad and well-coordinated portfolio of minimally invasive and non-invasive skin rejuvenation measures ensures that the needs and wishes of each patient can be individually addressed during treatment.

    Learn more about the portfolio of products that fuels confidence in every person.

    Read more
  • Dedicated to the development of neurotoxin therapy

    For patients with movement disorders, botulinum neurotoxin is often the treatment of choice. Merz´s expertise in this area has produced the only botulinum neurotoxin free from complexing proteins.

    Read more

    We are constantly working to advance new treatment standards and improve the quality of research, education and patient care.

  • Consumer Care

    Everything began with a cold bath – more than 50 years ago. Since then, tetesept offers a large selection of high-quality and at the same time innovative health products. The extensive product range extends from bath additives to cold remedies, vitamins & minerals to self-medication products. The products are available in Germany, Austria and Switzerland.

    Merz Consumer Care launched tetesept 'foot care'. The first foot care series from tetesept offers cosmetic and therapeutic products for the feet.

    Read more
  • Celebrating 110 years of Merz

    110 years ago, on March 9, 1918, the pharmacist and chemist Friedrich Merz founded the Chemische Fabrik Merz & Co. in Frankfurt am Main, Germany. Today, Merz remains a family-owned company, but has evolved into a global leader in aesthetic medicine and neurotoxin therapy.

    The motto of Friedrich Merz, who was born in 1884 in the town of Groß-Bieberau in the German Odenwald mountain range, was: “Trust yourself, be different, and invent products that are truly needed.“

    Read more


XEOMIN® (incobotulinumtoxinA) Receives European Approval for the Treatment of Chronic Sialorrhea in Children

Frankfurt, Germany /

First and only botulinum neurotoxin approved for this indication in Europe  Today, Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, has been…

Read more

Merz and Israeli start-up Vensica launch partnership for needleless treatment of overactive bladder

Frankfurt, Germany /

Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, and the Israeli start-up Vensica Therapeutics Ltd., a urology company, announced today that they…

Read more

Teijin Receives Additional Approval in Japan for Merz’s Xeomin® Botulinum Toxin Type A

Frankfurt, Germany /

Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, jointly…

Read more

Contact Us

If you would like to submit a speculative application or apply for an open position, please make sure
to use only our job portal, which you can find at the following link:
Please note that we cannot consider your application if you send it via any other channel.

* mandatory fields

Please note that if you submit information to Merz all materials submitted by electronic or physical communication will be deemed non-confidential. Do not submit any information or other materials that you consider to be confidential or proprietary. While we have no intention to publicly disclose any details of your proposal, we may refer to select experts within or outside the Merz network for evaluation.